Targeting Microglial Activation for Treatment of Autism Spectrum Disorder (ASD): A Proof-of-Concept, Target-Engagement Study
Phase of Trial: Phase I
Latest Information Update: 21 May 2018
At a glance
- Drugs Minocycline (Primary)
- Indications Pervasive child development disorders
- Focus Pharmacodynamics; Proof of concept
- 08 May 2018 Planned End Date changed from 1 Oct 2018 to 1 Dec 2019.
- 08 May 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2019.
- 21 Apr 2017 New trial record